Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 2, 1998
Blind to the danger?
W H Yee
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 1, 1990
Accidental strangulation by window-blind cords
W H Yee
Physiological Chemistry and Physics
|
January 1, 1973
A note on the effect of electromagnetic field on enzymic substrates
R L Sherman, S T Siebert, W H Yee
Journal of Perinatology : Official Journal of the California Perinatal Association
|
November 21, 2008
Relationship between oxygen saturation and the mode of oxygen delivery used in newborn resuscitation
Y Rabi, S Y Chen, W H Yee, et al.
Cell Cycle (Georgetown, Tex.)
|
July 24, 2009
The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
Marcus M Schittenhelm, Kerstin M Kampa, Kevin W H Yee, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 11, 2001
Evaluation of the effectiveness of the standardized neonatal resuscitation program
N Singhal, D D McMillan, W H Yee, et al.
Blood
|
August 12, 2004
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells
Kevin W H Yee, Marcus Schittenhelm, Anne-Marie O'Farrell, et al.
Blood
|
August 12, 2004
Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970
Amie S Corbin, Ian J Griswold, Paul La Rosée, et al.
Blood
|
September 28, 2002
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase
Kevin W H Yee, Anne Marie O'Farrell, Beverly D Smolich, et al.
Leukemia
|
September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)
M M Schittenhelm, K W H Yee, J W Tyner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 2, 1998
Blind to the danger?
W H Yee
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 1, 1990
Accidental strangulation by window-blind cords
W H Yee
Physiological Chemistry and Physics
|
January 1, 1973
A note on the effect of electromagnetic field on enzymic substrates
R L Sherman, S T Siebert, W H Yee
Journal of Perinatology : Official Journal of the California Perinatal Association
|
November 21, 2008
Relationship between oxygen saturation and the mode of oxygen delivery used in newborn resuscitation
Y Rabi, S Y Chen, W H Yee, et al.
Cell Cycle (Georgetown, Tex.)
|
July 24, 2009
The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
Marcus M Schittenhelm, Kerstin M Kampa, Kevin W H Yee, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 11, 2001
Evaluation of the effectiveness of the standardized neonatal resuscitation program
N Singhal, D D McMillan, W H Yee, et al.
Blood
|
August 12, 2004
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells
Kevin W H Yee, Marcus Schittenhelm, Anne-Marie O'Farrell, et al.
Blood
|
August 12, 2004
Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970
Amie S Corbin, Ian J Griswold, Paul La Rosée, et al.
Blood
|
September 28, 2002
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase
Kevin W H Yee, Anne Marie O'Farrell, Beverly D Smolich, et al.
Leukemia
|
September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)
M M Schittenhelm, K W H Yee, J W Tyner, et al.
Page
of 2